WeVote
Log In

Bill

Bill

HB 1502

Baltimore City - AIDS Prevention Sterile Needle and Syringe Exchange Pilot Program - Revisions

2025 Regular Session Introduced by Melissa Wells

Maryland revises Baltimore's needle exchange pilot program to strengthen HIV/hepatitis C prevention among people who inject drugs through operational updates.

Approved by the Governor - Chapter 758
0
WeVote Research Nonpartisan
Bill Summary · HB 1502

Legislative bill overview

HB 1502 revises Maryland's existing AIDS prevention sterile needle and syringe exchange pilot program in Baltimore City, modifying operational parameters or authorization terms for the program. The bill was introduced by Delegate Melissa Wells and became law in May 2025 after passing both legislative chambers and receiving gubernatorial approval.

Why is this important

Needle and syringe exchange programs (NSPs) are evidence-based public health interventions that reduce HIV and hepatitis C transmission among people who inject drugs while connecting participants to treatment services. This revision suggests the state is refining or expanding Baltimore's program based on pilot results, which has implications for disease prevention costs and public health infrastructure in the city.

Potential points of contention

  • Funding concerns: Questions about taxpayer investment in programs serving drug-using populations, despite demonstrated public health return-on-investment
  • Community safety perceptions: Local resident concerns about program visibility, syringe disposal protocols, or neighborhood impact despite evidence that NSPs don't increase drug use or crime
  • Scope of revision: The specific modifications aren't detailed in available records, creating uncertainty about whether changes expand, restrict, or merely clarify the program

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.